EnMotion, Embryo's Natural Motion

Study Overview
=================
Brief Summary
-----------------
The purpose of the study is to determine if a dynamic embryo microenvironment impacts embryo development and reproductive potential in comparison to static culture.

Detailed Description
-----------------
The proposed research design is a prospective randomized control trial. Patients with normal ovarian reserve, who would be expected to have reasonable outcomes after in vitro fertilization, will serve as the subjects. Embryos from the same patient will be randomized to either static or dynamic culture. They will then be cultured to the blastocyst stage of embryo development and biopsied for preimplantation genetic screening. The best chromosomally normal embryo from each culture group will be selected and transferred to complete a double embryo transfer in a subsequent frozen embryo transfer cycle the following month.

Official Title
-----------------
EnMotion, Embryo's Natural Motion: The Impact of Dynamic Culture on the Development of Useable Blastocysts

Conditions
-----------------
Infertility

Intervention / Treatment
-----------------
* Other: Dynamic culture platform


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Infertile women seeking in vitro fertilization treatment with aneuploidy screening Patient is eligible for a two-embryo transfer in compliance with ASRM guidelines Patient able to undergo a frozen embryo transfer cycle the month following the vaginal oocyte retrieval procedure Maximum day 3 Follicle-stimulating hormone level (≤12 IU/L) Anti-mullerian hormone level ≥ 1.2g/mL, tested within previous year ≤1 prior failed IVF cycle Male partner with >100,000 total motile spermatozoa per ejaculate (donor sperm acceptable) Body Mass Index ≤ 32 Antral Follicle Count ≥ 8 Exclusion Criteria: Diagnosis of endometrial insufficiency defined as a prior cycle with maximal endometrial thickness ≤ 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), persistent endometrial fluid Use of oocyte donation Use of gestational carrier Medical contraindication to double embryo transfer Use of testicular aspiration or biopsy procedures to obtain sperm Presence of a hydrosalpinx that communicates with the endometrial cavity Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation Single gene disorder requiring more detailed embryo genetic analysis

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 42 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Dynamic Culture Platform<br>Embryos randomized to the dynamic arm will be placed on the NSSB-300 microvibration platform within the designated incubator. The platform will vibrate at a strength setting of 4 for 5 seconds every 60 minutes. The embryos will be placed on the platform at the two pronucleur stage of development and remain on the platform until the blastocyst stage of development at which time the embryos will be biopsied for preimplantation genetic screening and frozen. | Other: Dynamic culture platform<br>* Patients will have their cohort of embryos split in half. Half will be cultured in the dynamic platform and the other half cultured in static.<br>* Other names: NSSB-300 microvibration platform;|
| No Intervention: Static Culture<br>The embryos randomized to the static or control arm of the study will be placed directly into the incubator and will not have any additional vibration, per routine care. The embryos will be placed in the incubator at the two pronucleur stage of development and remain in the incubator until the blastocyst stage of development at which time the embryos will be biopsied for preimplantation genetic screening and frozen. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Blastulation Rate | the number of blastocysts will be counted | 6 days post vaginal oocyte retrieval procedure | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Clinical Pregnancy Rate | documented intrauterine pregnancy | approximately 20-25 days post embryo transfer procedure | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Preimplantation Embryo Development